The Health team works with a long list of the world’s largest Pharmaceutical and Biotech companies on a range of assignments at both Global and at domestic UK level. We operate at corporate and above brand level as well as having significant experience across multiple therapeutic areas including Oncology, CVRM, Respiratory Health, Novel Diagnostics, Rare Disease and Neurological Conditions.

With specialisms in Policy and Public Affairs, Communications and Advocacy, companies commission us to help solve a range of challenges, particularly in understanding and shaping the environment into which new therapies and treatments are launched.

• Inertia – We inspire decision makers to act by making them care as much as the patients whose lives are in their hands
• Complexity – We help the best breakthroughs move effectively through a system struggling to cope with the pace of scientific and social progress
• Prioritisation – We educate decision-makers on the value of health interventions to secure investment and resources
• Ignorance – We raise awareness, fight stigma and help people take control of their health and navigate health systems

Recent highlights include:

• Supporting the development and socialisation of the Narrative for one of the UK’s leading pharmaceutical companies
• Delivering a series of meetings on behalf of a number of our clients at international congresses including ASCO, ESMO, ERS, EHA, ISPOR Europe and HTAi
• Mapping the global policy environment for the arrival of Cell and Gene therapies, across a range of therapeutic areas
• Securing Abstracts on policy related recommendations in a number of global scientific journals
• Working with international experts to develop Patient Charters in Sickle Cell Disease and Chronic Lymphocytic Leukemia